| REQTX | RWEBX | REQTX / RWEBX | |
| Total Expense Ratio | 1.01 | 1.06 | 95% |
| Annual Report Gross Expense Ratio | 1.10 | 1.06 | 104% |
| Fund Existence | 18 years | 12 years | - |
| Gain YTD | 7.433 | 5.239 | 142% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 276M | 214B | 0% |
| Annual Yield % from dividends | 0.74 | 0.75 | 98% |
| Returns for 1 year | 5.56 | 7.24 | 77% |
| Returns for 3 years | 13.75 | 29.98 | 46% |
| Returns for 5 years | -15.49 | 22.77 | -68% |
| Returns for 10 years | -2.51 | 78.62 | -3% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBEU | 77.99 | 0.40 | +0.52% |
| JPMorgan BetaBuilders Europe ETF | |||
| DOGD | 13.86 | N/A | N/A |
| Tradr 2X Long DDOG Daily ETF | |||
| BBBL | 47.95 | -0.11 | -0.24% |
| BondBloxx BBB Rated 10+ Yr Corp Bd ETF | |||
| SBI | 7.79 | -0.03 | -0.38% |
| Western Asset Intermediate Muni Fund | |||
| HQL | 17.18 | -0.42 | -2.39% |
| abrdn Life Sciences Investors | |||